Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...
A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard ...
Counterfeit Ozempic pens, which appear to be relabelled insulin pens, have been detected in Australia and have caused a ...
We take a look at some of the exciting diabetes research developments announced in October, and what the findings could mean for people living with or affected by diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback